跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 194 条关于
“SIDEROS”
全部
194
临床试验
169
药物
0
机构
1
资讯
24
去年
FDA Requests Additional Phase 3 Trial for Santhera's DMD Drug Raxone, Delaying Approval
去年
Donanemab's Modified Titration Significantly Reduces ARIA-E Risk in Alzheimer's Patients
去年
Trontinemab Shows Promise in Alzheimer's, but Safety Concerns Emerge
去年
Gantenerumab's ARIA-E Risk Factors Identified in Alzheimer's Trials
去年
Meta-Analysis Reveals Safety Differences Between Lecanemab and Donanemab in Early Alzheimer's Disease Treatment
去年
FDA Approves AI Tool icobrain aria for Detecting ARIA in Alzheimer's Immunotherapy Patients
去年
Roche's Trontinemab Shows Promise in Early Alzheimer's Data, Accelerated Approval Considered
去年
Eisai Submits BLA for Subcutaneous Leqembi Maintenance Dosing in the US
去年
Eisai Submits BLA for Subcutaneous Leqembi Maintenance Dosing in the US
去年
Eisai Completes FDA Submission for Subcutaneous Lecanemab in Early Alzheimer's
第 1 页,共 3 页
上一页
下一页